Activation of blood clotting in patients with systemic lupus erythematosus. Relationship to disease activity.
D000293:Adolescent; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D001168:Arthritis / Q000097:blood / Q000188:drug therapy; D001777:Blood Coagulation; D004247:DNA / Q000276:immunology; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005921:Glomerulonephritis / Q000097:blood / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000188:drug therapy; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011863:Radioimmunoassay; D012075:Remission, Spontaneous
D000974:Antibodies, Antinuclear; D005338:Fibrin Fibrinogen Degradation Products; D004247:DNA; D011241:Prednisone